Hmdb loader
Record Information
Version5.0
StatusDetected but not Quantified
Creation Date2021-09-11 01:51:18 UTC
Update Date2021-09-26 22:58:49 UTC
HMDB IDHMDB0248505
Secondary Accession NumbersNone
Metabolite Identification
Common NameApatinib
DescriptionApatinib, also known as apatinib mesylate or rivoceranib, belongs to the class of organic compounds known as aromatic anilides. These are aromatic compounds containing an anilide group in which the carboxamide group is substituted with an aromatic group. They have the general structure RNC(=O)R', where R= benzene, and R = aryl group. Based on a literature review a significant number of articles have been published on Apatinib. This compound has been identified in human blood as reported by (PMID: 31557052 ). Apatinib is not a naturally occurring metabolite and is only found in those individuals exposed to this compound or its derivatives. Technically Apatinib is part of the human exposome. The exposome can be defined as the collection of all the exposures of an individual in a lifetime and how those exposures relate to health. An individual's exposure begins before birth and includes insults from environmental and occupational sources.
Structure
Thumb
Synonyms
ValueSource
Apatinib mesylateHMDB
RivoceranibHMDB
Rivoceranib mesylateHMDB
Chemical FormulaC24H23N5O
Average Molecular Weight397.482
Monoisotopic Molecular Weight397.190260381
IUPAC NameN-[4-(1-cyanocyclopentyl)phenyl]-2-{[(pyridin-4-yl)methyl]amino}pyridine-3-carboxamide
Traditional NameN-[4-(1-cyanocyclopentyl)phenyl]-2-[(pyridin-4-ylmethyl)amino]pyridine-3-carboxamide
CAS Registry NumberNot Available
SMILES
O=C(NC1=CC=C(C=C1)C1(CCCC1)C#N)C1=C(NCC2=CC=NC=C2)N=CC=C1
InChI Identifier
InChI=1S/C24H23N5O/c25-17-24(11-1-2-12-24)19-5-7-20(8-6-19)29-23(30)21-4-3-13-27-22(21)28-16-18-9-14-26-15-10-18/h3-10,13-15H,1-2,11-12,16H2,(H,27,28)(H,29,30)
InChI KeyWPEWQEMJFLWMLV-UHFFFAOYSA-N
Chemical Taxonomy
Description Belongs to the class of organic compounds known as aromatic anilides. These are aromatic compounds containing an anilide group in which the carboxamide group is substituted with an aromatic group. They have the general structure RNC(=O)R', where R= benzene, and R = aryl group.
KingdomOrganic compounds
Super ClassBenzenoids
ClassBenzene and substituted derivatives
Sub ClassAnilides
Direct ParentAromatic anilides
Alternative Parents
Substituents
  • Aromatic anilide
  • Nicotinamide
  • Pyridinecarboxamide
  • Pyridine carboxylic acid or derivatives
  • Aminopyridine
  • Pyridine
  • Imidolactam
  • Heteroaromatic compound
  • Vinylogous amide
  • Secondary carboxylic acid amide
  • Carboxamide group
  • Nitrile
  • Carbonitrile
  • Carboxylic acid derivative
  • Organoheterocyclic compound
  • Azacycle
  • Organic nitrogen compound
  • Amine
  • Hydrocarbon derivative
  • Organic oxide
  • Cyanide
  • Organooxygen compound
  • Organonitrogen compound
  • Organic oxygen compound
  • Aromatic heteromonocyclic compound
Molecular FrameworkAromatic heteromonocyclic compounds
External DescriptorsNot Available
Ontology
Physiological effectNot Available
Disposition
ProcessNot Available
RoleNot Available
Physical Properties
StateNot Available
Experimental Molecular Properties
PropertyValueReference
Melting PointNot AvailableNot Available
Boiling PointNot AvailableNot Available
Water SolubilityNot AvailableNot Available
LogPNot AvailableNot Available
Experimental Chromatographic PropertiesNot Available
Predicted Molecular Properties
PropertyValueSource
logP3.14ALOGPS
logP4.29ChemAxon
logS-4.5ALOGPS
pKa (Strongest Acidic)13.45ChemAxon
pKa (Strongest Basic)5.41ChemAxon
Physiological Charge0ChemAxon
Hydrogen Acceptor Count5ChemAxon
Hydrogen Donor Count2ChemAxon
Polar Surface Area90.7 ŲChemAxon
Rotatable Bond Count6ChemAxon
Refractivity119.16 m³·mol⁻¹ChemAxon
Polarizability43.6 ųChemAxon
Number of Rings4ChemAxon
BioavailabilityYesChemAxon
Rule of FiveYesChemAxon
Ghose FilterYesChemAxon
Veber's RuleNoChemAxon
MDDR-like RuleYesChemAxon
Predicted Chromatographic Properties

Predicted Collision Cross Sections

PredictorAdduct TypeCCS Value (Å2)Reference
DeepCCS[M+H]+196.64930932474
DeepCCS[M-H]-194.29130932474
DeepCCS[M-2H]-228.2630932474
DeepCCS[M+Na]+203.45430932474
AllCCS[M+H]+196.232859911
AllCCS[M+H-H2O]+193.932859911
AllCCS[M+NH4]+198.332859911
AllCCS[M+Na]+198.932859911
AllCCS[M-H]-190.632859911
AllCCS[M+Na-2H]-190.732859911
AllCCS[M+HCOO]-190.932859911

Predicted Kovats Retention Indices

Underivatized

MetaboliteSMILESKovats RI ValueColumn TypeReference
ApatinibO=C(NC1=CC=C(C=C1)C1(CCCC1)C#N)C1=C(NCC2=CC=NC=C2)N=CC=C14790.1Standard polar33892256
ApatinibO=C(NC1=CC=C(C=C1)C1(CCCC1)C#N)C1=C(NCC2=CC=NC=C2)N=CC=C13675.0Standard non polar33892256
ApatinibO=C(NC1=CC=C(C=C1)C1(CCCC1)C#N)C1=C(NCC2=CC=NC=C2)N=CC=C13908.1Semi standard non polar33892256

Derivatized

Derivative Name / StructureSMILESKovats RI ValueColumn TypeReference
Apatinib,1TMS,isomer #1C[Si](C)(C)N(C(=O)C1=CC=CN=C1NCC1=CC=NC=C1)C1=CC=C(C2(C#N)CCCC2)C=C13558.4Semi standard non polar33892256
Apatinib,1TMS,isomer #1C[Si](C)(C)N(C(=O)C1=CC=CN=C1NCC1=CC=NC=C1)C1=CC=C(C2(C#N)CCCC2)C=C13406.4Standard non polar33892256
Apatinib,1TMS,isomer #1C[Si](C)(C)N(C(=O)C1=CC=CN=C1NCC1=CC=NC=C1)C1=CC=C(C2(C#N)CCCC2)C=C14824.3Standard polar33892256
Apatinib,1TMS,isomer #2C[Si](C)(C)N(CC1=CC=NC=C1)C1=NC=CC=C1C(=O)NC1=CC=C(C2(C#N)CCCC2)C=C13535.9Semi standard non polar33892256
Apatinib,1TMS,isomer #2C[Si](C)(C)N(CC1=CC=NC=C1)C1=NC=CC=C1C(=O)NC1=CC=C(C2(C#N)CCCC2)C=C13485.8Standard non polar33892256
Apatinib,1TMS,isomer #2C[Si](C)(C)N(CC1=CC=NC=C1)C1=NC=CC=C1C(=O)NC1=CC=C(C2(C#N)CCCC2)C=C14764.2Standard polar33892256
Apatinib,2TMS,isomer #1C[Si](C)(C)N(CC1=CC=NC=C1)C1=NC=CC=C1C(=O)N(C1=CC=C(C2(C#N)CCCC2)C=C1)[Si](C)(C)C3392.1Semi standard non polar33892256
Apatinib,2TMS,isomer #1C[Si](C)(C)N(CC1=CC=NC=C1)C1=NC=CC=C1C(=O)N(C1=CC=C(C2(C#N)CCCC2)C=C1)[Si](C)(C)C3335.1Standard non polar33892256
Apatinib,2TMS,isomer #1C[Si](C)(C)N(CC1=CC=NC=C1)C1=NC=CC=C1C(=O)N(C1=CC=C(C2(C#N)CCCC2)C=C1)[Si](C)(C)C4502.4Standard polar33892256
Apatinib,1TBDMS,isomer #1CC(C)(C)[Si](C)(C)N(C(=O)C1=CC=CN=C1NCC1=CC=NC=C1)C1=CC=C(C2(C#N)CCCC2)C=C13815.4Semi standard non polar33892256
Apatinib,1TBDMS,isomer #1CC(C)(C)[Si](C)(C)N(C(=O)C1=CC=CN=C1NCC1=CC=NC=C1)C1=CC=C(C2(C#N)CCCC2)C=C13604.2Standard non polar33892256
Apatinib,1TBDMS,isomer #1CC(C)(C)[Si](C)(C)N(C(=O)C1=CC=CN=C1NCC1=CC=NC=C1)C1=CC=C(C2(C#N)CCCC2)C=C14884.7Standard polar33892256
Apatinib,1TBDMS,isomer #2CC(C)(C)[Si](C)(C)N(CC1=CC=NC=C1)C1=NC=CC=C1C(=O)NC1=CC=C(C2(C#N)CCCC2)C=C13790.0Semi standard non polar33892256
Apatinib,1TBDMS,isomer #2CC(C)(C)[Si](C)(C)N(CC1=CC=NC=C1)C1=NC=CC=C1C(=O)NC1=CC=C(C2(C#N)CCCC2)C=C13684.6Standard non polar33892256
Apatinib,1TBDMS,isomer #2CC(C)(C)[Si](C)(C)N(CC1=CC=NC=C1)C1=NC=CC=C1C(=O)NC1=CC=C(C2(C#N)CCCC2)C=C14834.0Standard polar33892256
Apatinib,2TBDMS,isomer #1CC(C)(C)[Si](C)(C)N(CC1=CC=NC=C1)C1=NC=CC=C1C(=O)N(C1=CC=C(C2(C#N)CCCC2)C=C1)[Si](C)(C)C(C)(C)C3804.2Semi standard non polar33892256
Apatinib,2TBDMS,isomer #1CC(C)(C)[Si](C)(C)N(CC1=CC=NC=C1)C1=NC=CC=C1C(=O)N(C1=CC=C(C2(C#N)CCCC2)C=C1)[Si](C)(C)C(C)(C)C3742.2Standard non polar33892256
Apatinib,2TBDMS,isomer #1CC(C)(C)[Si](C)(C)N(CC1=CC=NC=C1)C1=NC=CC=C1C(=O)N(C1=CC=C(C2(C#N)CCCC2)C=C1)[Si](C)(C)C(C)(C)C4598.9Standard polar33892256
Spectra

GC-MS Spectra

Spectrum TypeDescriptionSplash KeyDeposition DateSourceView
Predicted GC-MSPredicted GC-MS Spectrum - Apatinib GC-MS (Non-derivatized) - 70eV, Positivesplash10-029l-3629000000-87bfd347acd1bad169e82021-09-23Wishart LabView Spectrum
Predicted GC-MSPredicted GC-MS Spectrum - Apatinib GC-MS (Non-derivatized) - 70eV, PositiveNot Available2021-10-12Wishart LabView Spectrum

MS/MS Spectra

Spectrum TypeDescriptionSplash KeyDeposition DateSourceView
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - Apatinib 10V, Positive-QTOFsplash10-0005-3009000000-555776386257ed239a242021-10-12Wishart LabView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - Apatinib 20V, Positive-QTOFsplash10-0006-9013000000-fa9bd6b0baa38e5d7fdc2021-10-12Wishart LabView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - Apatinib 40V, Positive-QTOFsplash10-0006-9212000000-c28832382568608e54892021-10-12Wishart LabView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - Apatinib 10V, Negative-QTOFsplash10-0002-0309000000-e91607ae9a6cafc226352021-10-12Wishart LabView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - Apatinib 20V, Negative-QTOFsplash10-017j-1319000000-aa17ed1f43a8d47e70ea2021-10-12Wishart LabView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - Apatinib 40V, Negative-QTOFsplash10-0kc6-4918000000-7892360cd84bc556cc0e2021-10-12Wishart LabView Spectrum
Biological Properties
Cellular LocationsNot Available
Biospecimen Locations
  • Blood
Tissue LocationsNot Available
Pathways
Normal Concentrations
BiospecimenStatusValueAgeSexConditionReferenceDetails
BloodDetected but not QuantifiedNot QuantifiedNot SpecifiedNot SpecifiedNormal details
Abnormal Concentrations
Not Available
Associated Disorders and Diseases
Disease ReferencesNone
Associated OMIM IDsNone
DrugBank IDNot Available
Phenol Explorer Compound IDNot Available
FooDB IDNot Available
KNApSAcK IDNot Available
Chemspider ID9490441
KEGG Compound IDNot Available
BioCyc IDNot Available
BiGG IDNot Available
Wikipedia LinkApatinib
METLIN IDNot Available
PubChem Compound11315474
PDB IDNot Available
ChEBI IDNot Available
Food Biomarker OntologyNot Available
VMH IDNot Available
MarkerDB IDNot Available
Good Scents IDNot Available
References
Synthesis ReferenceNot Available
Material Safety Data Sheet (MSDS)Not Available
General References
  1. Barupal DK, Fiehn O: Generating the Blood Exposome Database Using a Comprehensive Text Mining and Database Fusion Approach. Environ Health Perspect. 2019 Sep;127(9):97008. doi: 10.1289/EHP4713. Epub 2019 Sep 26. [PubMed:31557052 ]